ANGLE is a world leading liquid biopsy company with pioneering products in cancer diagnostics and foetal health. ANGLEs lead product is the Parsortix cell separation system, which can capture very rare cells from blood. This includes circulating tumour cells CTCs in cancer patient blood even when there is less than one CTC in one billion healthy cells. The resulting liquid biopsy simple blood test enables the investigation of mutations in the patient s cancer for personalised cancer care. ANGLE has launched a product for the research market and has secured CE Mark regulatory approval for the clinical market in Europe. The FDA authorization is in process. ANGLE is also undertaking clinical studies, the first on of which is in Ovarian Cancer for a clinical application to triage women having surgery for an abnormal pelvic mass to identify those with ovarian cancer. patient clinical studies in both Europe and the US have reported positive headline data and the test is being optimized before moving to validation studies. ANGLE has announced the acquisition of certain assets of Axela Inc, a novel multiplex diagnostic tool for the analysis of DNA, RNA and proteins.
Quote | Angle Plc Surrey ADR (OTCMKTS:ANPCY)
Last: | $1.89 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $1.89 |
High: | $0 |
Low: | $0 |
Volume: | 62 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Angle Plc Surrey ADR (OTCMKTS:ANPCY)
PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE CTC HER2 assay being developed for HER2 targeted drugs and antibody drug conjugates presented at internationally renowned AACR Annual Meeting 2024 GUILDFORD, SURREY / ACCESSWIRE / April 8, 2024 / ANG...
PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE ANGLE presenting two posters highlighting the utility of the Company's new Portrait+ CTC Staining Kit and Portrait HER2 assay GUILDFORD, SURREY / ACCESSWIRE / March 22, 2024 / ANGLE plc (AIM:AG)(O...
Message Board Posts | Angle Plc Surrey ADR (OTCMKTS:ANPCY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Angle Plc Surrey ADR Company Name:
ANPCY Stock Symbol:
OTCMKTS Market:
PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE CTC HER2 assay being developed for HER2 targeted drugs and antibody drug conjugates presented at internationally renowned AACR Annual Meeting 2024 GUILDFORD, SURREY / ACCESSWIRE / April 8, 2024 / ANG...
PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE ANGLE presenting two posters highlighting the utility of the Company's new Portrait+ CTC Staining Kit and Portrait HER2 assay GUILDFORD, SURREY / ACCESSWIRE / March 22, 2024 / ANGLE plc (AIM:AG)(O...
REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY Paper published in the journal "Current Issues in Molecular Biology" special issue: advanced solutions for cancer therapy GUILDFORD, SURREY / ACCESSWIRE / January 22, 2024 / AN...